Welcome to BioMarket Group!

Partneringreview 2006 - Deal type (volume 5)

Additional Information

Published Date Feb 1, 2006
Special Offer No
Pages 3500
PDF Fact Sheet View Fact Sheet for the report Partneringreview 2006 - Deal type (volume 5) in PDF format.
Published on Date No
Format No
Publisher N/A
Product Line No
Full Title No

Availability: In stock

$2,495.00

Quick Overview

Identify the latest dealmaking trends in your industry
Request free sample pages from Partneringreview 2006 - Deal type (volume 5)

Partneringreview 2006- Volume 5: Deal type provides an in depth view into the deals and alliances by deal type announced in 2005, in a clear and accessible format.


The report reviews over 2,600 deal announcements by deal type including licensing, cross license, technology access, sublicense, evaluation, letter of intent, co-marketing, co-promotion, contract marketing, contract manufacture, marketing, promotion, OEM, purchase, supply, distribution, manufacturing, collaborative R&D, CRADA, co-development, contract development, contract research, development, and research deals.


Each sector is further divided to analyze deals by company, industry sector, therapy area, and stage of development.


Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed.


Each deal is annotated with a deal number, such as #43. This number links to the full deal in the deal listing at the rear of each report. When using the PDF format in Acrobat Reader, simply click on the number to move around the report.


All the year’s deals at a glance.


Want to know what your competitors are doing? Want to benchmark your deals against others in your therapeutic area or see how the finances of different deal types compare? Partneringreview 2006 brings all the 2005’s deals into focus in one place.Partneringreview is a comprehensive summary of the year’s deal announcements in a clear and accessible printable format. Every deal entry includes financial information where disclosed, such as headline values and upfront and milestone payments. A new addition of an overview of financings from investors is also included in this latest edition.

Request free sample pages from Partneringreview 2006 - Deal type (volume 5)

Other selected research from the 'Business Development' category:


Partnering Agreements with Forest 2010
The Partnering Agreements with Forest 2010 provides an in-depth insight into the partnering interests and activites of one of the worlds leading biopharma companies.
This report provides all the information you require to better understand Forest Labs and its partnering interests and activities over the past five years.
Learn More


US Stem Cell Market Analysis
The stem cell market has been growing at a fast pace for the past few years and despite recession, the US continued to witness positive developments and massive investments in... Learn More

Other selected research from the 'Licensing' category:


Pharmaceutical Outsourcing Part 2: An Introduction to Drug Discovery Strategies - new opportunities lie in a fully integrated global outsourcing strategy
The pharma industry is facing a crisis over R&D productivity, as reflected by the low level of new drug approvals despite companies investing the highest ever amounts in R&D. As a result, companies are seeking novel ways to drive growth, with many opting to increase their reliance on third parties - through licensing, collaborative and outsourcing agreements - in an attempt to achieve this. Learn More


Combined Bigpharma Dealmaking and Agreements Handbook 2007
Combined Bigpharma Dealmaking and Agreements Handbook 2007 provides an indepth access to the dealmaking interests, activity and partnering agreements entered into by the worlds leading fifty biopharma companies Learn More

Other selected research from the 'Pharmacoeconomics' category:


Pharmacogenomics for Clinical Use and in Drug Development
Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Learn More


Website Benchmarking Tool: US Healthcare Professional Targeted Websites
Healthcare professionals have little time during their work day to search for drug- and disease-related information. Time pressures also limit the amount of time that prescribers are able to spend with sales representatives from pharmaceutical companies. For these reasons many prescribers rely on websites provided by pharmaceutical companies when searching for treatment information. Learn More

Other selected research from the 'Production' category:


Pharmaceutical Supply chain strategies: Reassessing product distribution to cut costs and improve supply chain management
This report provides an overview of the pharmaceutical distribution model in Europe and the US, and highlights recent changes in the supply chain that impact on the industry, particularly with regards to parallel trade and counterfeit strategies. Learn More


Partneringreview 2006 - Deal type (volume 5)
Identify the latest dealmaking trends in your industry Learn More

Other selected research from the 'R&D' category:


Targeted Cancer Therapies: Innovative drugs and their impact on the future of oncology
This report assesses the role of targeted cancer therapies as a driver of growth in the cancer market and their future role potential. Learn More


Live-Licensing & In-life testing: R&D Processes and Regulation for New Drugs, 2008-2020
This report predicts that the current phase I to IV clinical testing process will eventually be selectively or wholly replaced by a system known as "in-life" testing or "live" licensing. Learn More